卵巢子宫内膜异位囊肿术后药物治疗进展:GnRH-a、地诺孕素及LNG-IUS的应用

Journal: Basic Medical Theory Research DOI: 10.12238/bmtr.v8i1.18542

耿鑫宇, 张雅丽

承德医学院附属医院

Abstract

卵巢子宫内膜异位囊肿(OE)术后高复发率是临床关键挑战,术后药物辅助治疗以抑制残留病灶、缓解疼痛、降低复发为核心目标。本文系统综述 GnRH-a(如亮丙瑞林)、地诺孕素(DNG)、LNG-IUS 的单药疗效、安全性、疗程争议及联合策略。研究显示,GnRH-a 短期治疗(3~6个月)快速抑灶但需警惕骨丢失;DNG长期治疗(≥12个月)疗效与骨密度安全性均衡;LNG-IUS局部释药降复发,适用于无生育需求者。联合方案(如GnRH-a序贯DNG或LNG-IUS)在提升妊娠率、延缓复发上具协同效应,最佳疗程及安全性仍需大样本研究验证,本综述为临床个体化治疗提供循证依据。

Keywords

卵巢子宫内膜异位囊肿;术后治疗;促性腺激素释放激素激动剂;地诺孕素;左炔诺孕酮宫内缓释系统

References

[1] Zheng Q,Mao H,Xu Y,et al.Can postoperative GnRH agon
[2] 王晶,陈滢,杨赛花.腹腔镜手术前后联合醋酸亮丙瑞林治疗子宫内膜异位症的比较研究[J].中国微创外科杂志,2011,11
[3] 张苗,应超,李明珠.注射用醋酸亮丙瑞林微球对子宫内膜异位症腹腔镜术后患者的临床价值[J].中国妇幼保健,2021,36
[4] 何春妮,宋岩峰.长效促性腺激素释放激素激动剂治疗子宫内膜异位症的疗效观察[J].世界医学杂志,2001,5(5):47-48.
[5] 王久兰,何伟,周夏伶,等.地诺孕素、亮丙瑞林辅助治疗卵巢子宫内膜异位囊肿的临床效果比较[J].中国妇产科临床杂志,2022,23(03):275-277.
[6] LiZ, yuan Zhang H, jun Zhu Y, et al. A randomized study comparing the side effects and hormonal status of triptorelin and leuprorelin following conservative laparoscopic surgery for ovarian endometriosis in Chinese women[J].European Journ
[7] Muzii L,Galati G, Di Tucci C,et al.Medical treatment of ovarian endometriomas:a prospective evaluation of the effect of dienogest on ovarian reserve, cyst diameter, and associated pain[J].Gynecological Endocrinology,2020,36(1):81-83.
[8] Römer T.Long-term treatment of endometriosis with dienogest:retrospective analysis of efficacy and safety in clinical practice[J].Archives of gynecology and obstetrics, 2018,298:747-753.
[9] Seo J W, Lee D Y, Yoon B K, et al. Effects of long-term postoperative dienogest use for treatment of endometriosis on bone mineral density[J].European Journal of Obstetrics & Gynecology and Reproductive Biology,2017,212:9-12.

Copyright © 2026 耿鑫宇, 张雅丽

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License